中国罕见病治理经验及其国际参考价值

China's rare disease treatment and management pattern and its international significance

  • 摘要:
    目的 罕见病治理是全球性公共卫生难题。本研究旨在系统梳理中国覆盖“预防-诊疗-用药-保障”的全链条治理模式,总结其具体举措与成效,并探讨其对国际社会的参考价值。
    方法 通过对中国近年来相关政策、法规及实践进行系统性回顾,剖析其在定义、诊疗、保障、药物及预防5个核心环节构建的综合治理模式。
    结果 中国的治理实践形成了一套系统性应对罕见病挑战的解决方案。为破解数据缺乏的定义困局,中国创新性地采用“目录制”明确了207种罕见病范围。为应对地域广阔、资源不均的难题,建立了覆盖全国的诊疗协作网以提升诊疗效率。为解决高价药的可负担性问题,构建了整合社会与商业力量的多层次医疗保障体系。同时,实施“研发引进并重”的药物策略以平衡供需,并通过三级防控体系将干预关口前移。
    结论 中国的“全链条、多层次”治理模式为发展中国家提供了宝贵的实践经验。其在目录定义、协作网建设和多元保障等方面的创新,为构建符合各国国情的罕见病治理体系贡献了“中国方案”。

     

    Abstract:
    Objective The treatment and management of rare diseases is a global public health challenge. This paper fully summarizes the treatment and management pattern of rare disease in China, covering prevention, diagnosis, medication and medical security, evaluate the performance of each measure and discuss its international significance.
    Methods A thorough analysis on China’s policies, regulations about rate disease, and their implementation in recent years was conducted, focusing on disease definition, diagnosis and treatment, medical security, medicines, and prevention of rare disease.
    Results : China has made a series of solution for the challenge caused by rare disease in the practice of treatment and management of such disease. To address the problem of rare disease definition due to limited epidemiological data, a rare disease list was made out for the first time in China, covering 207 conditions. To address the challenges of vast territory of China and uneven distribution of medical resources in China, a nationwide collaborative medical service network was established to improve the disease diagnosis. To address the problem of high cost of medicines, a multi-tiered medical security system was established by integrating both social and commercial resources. To balance the supply and demand of medicines, an equal strategy for medicine development and importation was used. Based on the three-level prevention and control system, early intervention was conducted.
    Conclusion China’s "full-chain, multi-level" pattern of rare disease treatment and management has great significance for developing countries and the innovations of establishing rare disease list, collaboration network and multivariant medical security system have provided “China solution” for the treatment and management of rare disease in other countries based on their conditions.

     

/

返回文章
返回